Stock analysts at The Goldman Sachs Group started coverage on shares of Relx (NYSE:RELX – Get Free Report) in a note issued to investors on Wednesday. The brokerage set a “buy” rating on the technology company’s stock.
A number of other brokerages have also issued reports on RELX. Redburn Atlantic started coverage on shares of Relx in a report on Wednesday, January 8th. They issued a “buy” rating on the stock. StockNews.com lowered Relx from a “buy” rating to a “hold” rating in a research report on Tuesday, March 4th. Finally, Barclays raised Relx from an “equal weight” rating to an “overweight” rating in a research note on Friday, March 14th. One analyst has rated the stock with a hold rating, three have assigned a buy rating and one has assigned a strong buy rating to the stock. According to MarketBeat, the stock has an average rating of “Buy”.
Check Out Our Latest Stock Report on Relx
Relx Stock Up 1.2 %
Hedge Funds Weigh In On Relx
A number of institutional investors and hedge funds have recently made changes to their positions in RELX. CENTRAL TRUST Co boosted its stake in Relx by 1,290.2% in the 4th quarter. CENTRAL TRUST Co now owns 570 shares of the technology company’s stock worth $26,000 after purchasing an additional 529 shares in the last quarter. Versant Capital Management Inc purchased a new stake in shares of Relx during the fourth quarter valued at approximately $31,000. Transce3nd LLC bought a new stake in shares of Relx during the fourth quarter valued at approximately $40,000. Sierra Ocean LLC purchased a new position in Relx in the 4th quarter worth approximately $43,000. Finally, Brown Brothers Harriman & Co. raised its holdings in Relx by 218.5% in the 4th quarter. Brown Brothers Harriman & Co. now owns 965 shares of the technology company’s stock worth $44,000 after acquiring an additional 662 shares during the last quarter. Institutional investors own 15.02% of the company’s stock.
About Relx
RELX Plc engages in provision of information and analytics solutions for professional and business customers across industries. It operates through the following business segments: Scientific, Technical & Medical; Risk & Business Analytics; Legal; and Exhibitions. The Scientific, Technical & Medical segment is a global information analytics business that helps institutions and professionals advance healthcare, open science, and improve performance for the benefit of humanity.
Read More
- Five stocks we like better than Relx
- Breakout Stocks: What They Are and How to Identify Them
- Palantir Setting Up to Be a Big Winner With New Defense Spending
- Transportation Stocks Investing
- Advanced Micro Devices Can Double in Price: Here’s Why
- What Are Some of the Best Large-Cap Stocks to Buy?
- How Disney’s Experiences Segment Can Restore the House of Mouse
Receive News & Ratings for Relx Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Relx and related companies with MarketBeat.com's FREE daily email newsletter.